MimiVax

NY - Buffalo

Biotechnology

Focus: Immunotherapeutics

MimiVax is a life sciences company focused on Immunotherapeutics.

Oncology

Funding Stage

PRIVATE

Employees

5000+

Open Jobs

Pipeline & Clinical Trials

SurVaxM

Phase 2

Clinical Trials (1)

NCT05163080SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)

Phase 2

No open positions listed yet.

Interview Prep Quick Facts

Founded: 2012

Portfolio: 1 clinical trial

Top TAs: Oncology

Publications: 4 in PubMed

Therapeutic Area Focus

1 pipeline

Marketed

Pipeline